SEC Info - Glaxosmithkline PLC, et al.

SEC Info℠

Home

Help

Please Sign In

Glaxosmithkline PLC, et al. – ‘6-K’ for 3/18/13

On: Monday, 3/18/13, at 1:19pm ET · For: 3/18/13 · Accession #: 1193125-13-111964 · File #s: 1-15170, 1-34068, 1-35541

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 3/18/13  Glaxosmithkline PLC               6-K         3/18/13    5:511K                                   Donnelley … Solutions/FA
          Glaxosmithkline Capital Inc
          Glaxosmithkline Capital PLC

Current Report by a Foreign Private Issuer — Form 6-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 6-K         Current Report by a Foreign Private Issuer          HTML     16K 
 2: EX-1.1      Underwriting Agreement                              HTML    227K 
 3: EX-4.1      Instrument Defining the Rights of Security Holders  HTML     29K 
 4: EX-5.1      Opinion re: Legality                                HTML     18K 
 5: EX-5.2      Opinion re: Legality                                HTML     32K

6-K — Current Report by a Foreign Private Issuer

This is an HTML Document rendered as filed. [ Alternative Formats ]

Form 6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

FORM 6-K

Report of Foreign Issuer

Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934

March 18, 2013

GlaxoSmithKline plc

GlaxoSmithKline Capital plc

GlaxoSmithKline Capital Inc.

(Name of registrant)

980 Great West Road, Brentford,

Middlesex, TW8 9GS

1105 North Market Street, Suite 622,

Wilmington, Delaware 19801

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F x Form 40-F ¨

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ¨ No x

THIS REPORT ON FORM 6-K SHALL BE DEEMED TO BE INCORPORATED BY REFERENCE IN THE PROSPECTUS INCLUDED IN THE REGISTRATION STATEMENT ON FORM F-3 (FILE NO. 333-172621) OF GLAXOSMITHKLINE PLC, GLAXOSMITHKLINE CAPITAL PLC AND GLAXOSMITHKLINE CAPITAL INC. AND TO BE A PART THEREOF FROM THE DATE ON WHICH THIS REPORT IS FURNISHED, TO THE EXTENT NOT SUPERSEDED BY DOCUMENTS OR REPORTS SUBSEQUENTLY FILED OR FURNISHED.

GlaxoSmithKline plc, GlaxoSmithKline Capital plc and GlaxoSmithKline Capital Inc. hereby incorporate by reference the following exhibits to this report on Form 6-K into their Registration Statement on Form F-3 (File Nos. 333-172621, 333-172621-01, 333-172621-02).


Exhibit No.		Description of Document

1.1		Underwriting Agreement, dated as of March 13, 2013, among GlaxoSmithKline Capital Inc., GlaxoSmithKline plc, Deutsche Bank Securities Inc., Goldman, Sachs & Co., J.P. Morgan Securities LLC and UBS Securities LLC, as representatives of the several underwriters named therein.

4.1		First Supplemental Indenture, dated as of March 18, 2013, among GlaxoSmithKline Capital Inc., GlaxoSmithKline plc and Law Debenture Trust Company of New York.

5.1		Opinion of Cleary Gottlieb Steen & Hamilton LLP, special U.S. counsel to GlaxoSmithKline plc and GlaxoSmithKline Capital Inc.

5.2		Opinion of Cleary Gottlieb Steen & Hamilton LLP, special English counsel to GlaxoSmithKline plc and GlaxoSmithKline Capital Inc.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned, thereunto duly authorised.


	GlaxoSmithKline plc
	GlaxoSmithKline Capital plc and
	GlaxoSmithKline Capital Inc.
	(Registrants)

Date: March 18, 2013

	By:	/s/ *Victoria Whyte*

	Victoria Whyte
	Authorised Signatory for and on behalf of
	GlaxoSmithKline plc
	GlaxoSmithKline Capital plc and
	GlaxoSmithKline Capital Inc.

Dates Referenced Herein and Documents Incorporated by Reference

This ‘6-K’ Filing	Date	Other Filings

Filed on / For Period End:	3/18/13	6-K
	3/13/13	424B2, 6-K
		List all Filings

3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/25/24  GSK plc                           F-3ASR      3/25/24   12:25M                                    Donnelley … Solutions/FA
 3/10/23  GSK plc                           POS AM                 8:893K                                   Donnelley … Solutions/FA
 3/26/21  GSK plc                           F-3ASR      3/26/21    8:916K                                   Donnelley … Solutions/FA

↑Top

Filing Submission 0001193125-13-111964 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)